Joseph G. Cannon
-
- Neurotransmitter Receptor Influence on Behavior 21
- Neuroscience and Neuropharmacology Research 18
- Organic Chemistry top 2%
- Asymmetric Synthesis and Catalysis 20
- Chemical synthesis and alkaloids 19
- Synthetic Organic Chemistry Methods 15
- Synthesis and pharmacology of benzodiazepine derivatives 13
- Biochemistry top 5%
- Pharmacology top 5%
- Molecular Biology top 10%
- Receptor Mechanisms and Signaling 28
- Chemical Synthesis and Analysis 16
Joseph G. Cannon
169 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 130
- Cellular and Molecular Neuroscience 771
- Organic Chemistry 736
- Biochemistry 144
- Pharmacology 133
- Molecular Biology 1.0k
Countries citing papers authored by Joseph G. Cannon
This map shows the geographic impact of Joseph G. Cannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph G. Cannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph G. Cannon more than expected).
Fields of papers citing papers by Joseph G. Cannon
This network shows the impact of papers produced by Joseph G. Cannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph G. Cannon. The network helps show where Joseph G. Cannon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joseph G. Cannon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 21 | |
| 2 | 1995 | 14 | |
| 3 | 1994 | 27 | |
| 4 | 1993 | 6 | |
| 5 | 1992 | 119 | |
| 6 | 1991 | 6 | |
| 7 | 1991 | 6 | |
| 8 | 1991 | 4 | |
| 9 | 1990 | 9 | |
| 10 | 1989 | 12 | |
| 11 | 1988 | 2 | |
| 12 | 1988 | 32 | |
| 13 | 1988 | 2 | |
| 14 | 1988 | 3 | |
| 15 | The Design of Potential Anti-Parkinsonian Drugs: What is the Dopaminergic Pharmacophore in Ergot Alkaloids? | 1986 | 0 |
| 16 | 1985 | 11 | |
| 17 | 1978 | 33 | |
| 18 | 1978 | 23 | |
| 19 | 1971 | 3 | |
| 20 | 1969 | 25 |
About Joseph G. Cannon
Joseph G. Cannon is a scholar working on Organic Chemistry, Cellular and Molecular Neuroscience and Biochemistry, having authored 180 papers that have together received 2.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (28 papers), Neurotransmitter Receptor Influence on Behavior (21 papers), Asymmetric Synthesis and Catalysis (20 papers), Chemical synthesis and alkaloids (19 papers), Neuroscience and Neuropharmacology Research (18 papers), Chemical Synthesis and Analysis (16 papers), Synthetic Organic Chemistry Methods (15 papers) and Synthesis and pharmacology of benzodiazepine derivatives (13 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (771 citations), Organic Chemistry (736 citations) and Biochemistry (144 citations). Joseph G. Cannon has collaborated with scholars based in United States, United Kingdom and Egypt. Frequent co-authors include John P. Long, B. Costall, Robert J. Naylor, Jan R. Flynn, J.P. Long, Theresa M. Lee, Ranbir K. Bhatnagar, Peter E. Hicks, Fouad M. Sharabi and John E. Garst. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.